Serum concentrations of TNF α and its soluble receptors in patients with adrenal tumors treated by surgery.

International Journal of Molecular Sciences
Jan KomorowskiHenryk Stepien

Abstract

The peripheral blood levels of TNF alpha and its soluble receptors were studied in 39 patients with malignant and benign adrenal tumors treated by adrenalectomy. The concentrations of TNF alpha were significantly elevated in patients with malignant tumors of the adrenal cortex and in patients with Conn's syndrome compared to control. In patients with non-functioning adenomas and pheochromocytomas, TNF alpha levels were similar to those detected in the control. In subjects with myelolipomas, the serum concentration of TNF alpha was lower compared to the control. After adrenalectomy, the levels of TNF alpha were decreased in patients with malignant tumors and in patients with Conn's syndrome, nonfunctioniong adenomas and pheochromocytomas compared to the concentration before surgery. The serum concentrations of soluble receptors of TNF alpha did not differ among different patient groups and compared to the control. After adrenalectomy, the blood concentrations of TNF alpha R1 and TNF alpha R2 were decreased in patients with Conn's syndrome. However, to confirm practicality of the evaluation of TNF alpha and its soluble receptors in differential diagnosis in patients with adrenal tumors, a larger study group is needed.

References

Feb 1, 1992·The Journal of Experimental Medicine·D AderkaD Wallach
Aug 1, 1992·Journal of Reproductive Immunology·R AustgulenT Espevik
Sep 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T AndusJ Schölmerich
Sep 1, 1992·Clinical and Experimental Immunology·A KalinkovichZ Bentwich
May 1, 1991·Immunology Today·S ChouaibW A Buurman
Mar 30, 1987·Biochemical and Biophysical Research Communications·L SchweigererD Gospodarowicz
Jan 1, 1995·Annual Review of Immunology·R L Wilder
Nov 1, 1994·The Journal of Clinical Endocrinology and Metabolism·J A Gonzalez-HernandezW A Scherbaum
Mar 1, 1994·Oncology·U Hieber, M E Heim
Feb 1, 1996·The Journal of Clinical Endocrinology and Metabolism·J A González-HernándezS R Bornstein
Nov 1, 1996·Endocrine Research·G PäthW A Scherbaum
Oct 23, 1998·Journal of Drug Targeting·A Corti, F Marcucci
Feb 26, 2000·Immunology Today·J D SedgwickH Körner
Jul 13, 2000·General and Comparative Endocrinology·G B CallA M Judd
Feb 28, 2002·British Journal of Pharmacology·David J MacEwan
Mar 19, 2002·Cellular Signalling·David J MacEwan
Apr 18, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zoya R YurkovetskyAnna E Lokshin
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Simone Mocellin, Donato Nitti
Sep 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Virginia Vila-del SolManuel Fresno
Sep 26, 2008·Biochemical and Biophysical Research Communications·Francisca Guardiola-SerranoJoachim Altschmied

❮ Previous
Next ❯

Citations

Apr 13, 2019·Endocrine Connections·Sofia S PereiraDuarte Pignatelli

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.